Europe Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Plasma Fractionation Market
The Europe Plasma Fractionation Market would witness market growth of 9.3% CAGR during the forecast period (2021-2027). Plasma fractionation refers to a separation method, which is adopted to extract plasma derivatives. There are various kinds of plasma derivatives accessible in the market such as albumin and immunoglobulins. These products have concentrated fractions of plasma protein, which is extracted with the help of fractionation of plasma collected from a huge number of donors.
Moreover, plasma derivatives are utilized in various medical domains like critical care, neurology, and hematology. For example, immunoglobulins are employed in neurology in order to assist patients who are suffering from multiple sclerosis and neuropathic pain. Furthermore, these products are widely utilized in research labs and hospitals, due to the increasing awareness regarding their usage in several medical domains.
Immunoglobulins are utilized as first-line therapy for several hematologic, immunologic, and neurologic conditions. The primary & common usage of immunoglobulin therapy is considered useful for treating the primary immune deficiencies and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Intravenous immunoglobulin (IVIg) is also being regarded for various neurological disorders, such as neuropathic pain, multiple sclerosis, and chronic fatigue syndrome.
In the past few years, the diagnosis rate of numerous immunological disorders has grown owing to technological developments. Additionally, increasing genetic research for characterizing and diagnosing immunodeficiency will grow the clinical requirement for immunoglobulins because of the higher number of diagnosed patients.
The Germany market dominated the Europe Public Sector Market by Country in 2020, thereby, achieving a market value of $579.9 Million by 2027. The UK market is exhibiting a CAGR of 8.9% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 10.3% during (2021 - 2027).
Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Based on Sector, the market is segmented into Private Sector and Public Sector. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Plasma Fractionation Market Size will Hit $28.2 Billion by 2027, at a CAGR of 9.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.
Scope of the Study
Market Segments Covered in the Report:
- Coagulation factor VIII
- Coagulation factor IX
- Private Sector
- Public Sector
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Emergent BioSolutions, Inc.
- CSL Limited
- Grifols S.A.
- Octapharma AG
- Takeda Pharmaceutical Company Limited
- Kedrion S.p.A
- LFB S.A
- Biotest AG (Tiancheng International Investment Limited)
- Sanquin Blood Supply Foundation
- Bio Products Laboratory Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free